Class II
Ongoing
Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL…
Why: CGMP Deviations
- Company
- Baxter Healthcare Corporation
Deerfield, IL, United States - Reported
- Sep 9, 2026
- Recall started
- Aug 6, 2026
- Where sold
- US Nationwide; Puerto Rico; and Chile.
- Amount
- N/A
- Full product description
- Famotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx Only, Sterile Nonpyrogenic, Baxter International Inc., Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-5197-41.
- Lots / codes affected
- Lot # NC188586, Exp Date: 02/28/2027; Lot # NC188913, Exp Date: 3/9/2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.